Search
Close this search box.

Plasma-Derived ApoA-1

Man experiencing chest pain

Findings suggest CSL112 can boost cholesterol efflux capacity in patients with impaired endogenous HDL function. Encouragingly, several studies have documented its ability to reduce atherosclerotic plaque volume.